Zdrowie i gospodarka · 16/02/2018
FDA Announces Guidance for Developing Prescription Drugs for Acute Migraine Treatment
The Food and Drug Administration (FDA) has released a guidance document to help pharmaceutical companies develop prescription medications for treating acute migraines, finalizing a draft issued in 2014.